Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-10
2007-04-10
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S131000
Reexamination Certificate
active
11241700
ABSTRACT:
Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
REFERENCES:
patent: 3192103 (1965-06-01), Sousa et al.
patent: 4016170 (1977-04-01), Nadelson
patent: 4022901 (1977-05-01), Narayanan et al.
patent: 4135910 (1979-01-01), Howe
patent: 4166732 (1979-09-01), Howe
patent: 4210762 (1980-07-01), Howe
patent: 4268299 (1981-05-01), Howe
patent: 5484944 (1996-01-01), Albaugh et al.
patent: 5972050 (1999-10-01), Wiesenfeldt et al.
patent: 6034106 (2000-03-01), Biftu et al.
patent: 6180648 (2001-01-01), Kozikowski et al.
patent: 6472422 (2002-10-01), Kozikowski et al.
patent: 6498151 (2002-12-01), Li et al.
patent: 6992096 (2006-01-01), Karp et al.
patent: 2002/0025976 (2002-02-01), Chu et al.
patent: 2002/0055521 (2002-05-01), Kozikowski et al.
patent: 2002/0147188 (2002-10-01), Cummings
patent: 2003/0045546 (2003-03-01), Cai et al.
patent: 2005/0154012 (2005-07-01), Cai et al.
patent: 675122 (1995-10-01), None
patent: 2001-247569 (2001-09-01), None
patent: 2002-105073 (2002-04-01), None
patent: WO 95/11885 (1995-05-01), None
patent: WO 97/09335 (1997-03-01), None
patent: WO 97/44333 (1997-11-01), None
patent: WO 97/46556 (1997-12-01), None
patent: WO 98/00465 (1998-01-01), None
patent: WO 98/33927 (1998-08-01), None
patent: WO 98/45263 (1998-10-01), None
patent: WO 98/49190 (1998-11-01), None
patent: WO 99/54317 (1999-10-01), None
patent: WO 2000-021959 (2000-04-01), None
patent: WO 2000-025768 (2000-05-01), None
patent: WO 2000-38687 (2000-07-01), None
patent: WO 2000-058278 (2000-10-01), None
patent: WO 2000-058280 (2000-10-01), None
patent: WO 2000-058304 (2000-10-01), None
patent: WO 2000-69810 (2000-11-01), None
patent: WO 2000-75120 (2000-12-01), None
patent: WO 2001-66534 (2001-09-01), None
patent: WO 2001/085723 (2001-11-01), None
patent: WO 2001-90101 (2001-11-01), None
patent: WO 02/100826 (2002-01-01), None
patent: WO 2002-072621 (2002-09-01), None
patent: WO 2002-085869 (2002-10-01), None
patent: WO 2003-02559 (2003-01-01), None
patent: WO 04/014370 (2004-02-01), None
patent: WO 04/014902 (2004-02-01), None
patent: WO 04/072050 (2004-08-01), None
patent: WO 04/110351 (2004-12-01), None
patent: WO 05/060961 (2005-07-01), None
patent: WO 05/077373 (2005-08-01), None
Sokolenko et al., 1972, Voprosy Khimii I Khimicheskoi Tekhnolugii No. 27:107-112 (with English language abstract).
Almstead Neil Gregory
Chen Guangming
Hwang Seongwoo
Karp Gary Mitchell
Moon Young-Choon
Chung Susannah L.
Jones Day
McKane Joseph K.
PTC Therapeutics, Inc.
LandOfFree
Benzoic acid or benzoate substituted 1,2,4-oxadiazole... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoic acid or benzoate substituted 1,2,4-oxadiazole..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoic acid or benzoate substituted 1,2,4-oxadiazole... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3732295